Ideally, no. But an occasional drink is realistic for many people on a GLP-1 like Ozempic, Wegovy or Zepbound, as long as you go slowly and you’re not in one of two groups: people taking insulin or a sulfonylurea for diabetes, and people who have had pancreatitis. Those two groups shouldn’t drink without talking to their doctor first.
It hits you faster
These medicines slow down how fast your stomach empties, so one drink can feel like two. Drink more slowly than you think you need to, and don’t drink on an empty stomach.
Many people stop wanting it
The same effect that quiets food noise often quiets the pull toward alcohol. There’s early research behind that: in a small 2025 trial, adults with alcohol use disorder who took semaglutide drank less per drinking day and reported less craving than those on placebo. The authors call the finding preliminary.
Who shouldn’t drink without asking first
- If you take insulin or a sulfonylurea (such as glipizide or glimepiride): a GLP-1 already raises the risk of low blood sugar with these medicines, and alcohol lowers blood sugar too. Together they can push it dangerously low. That’s not a “drink less” conversation; it’s a “talk to your doctor before you drink” one.
- If you’ve had pancreatitis: heavy drinking is one of the most common causes of pancreatitis, and pancreatitis has been reported with GLP-1 medicines.
The short version
It’s not never; it’s less. Go slowly, and know which group you’re in.
Sources
- Hendershot et al., JAMA Psychiatry, 2025: semaglutide and alcohol intake and craving (phase 2 trial, 48 adults)
- Zepbound prescribing information: slowed stomach emptying, low blood sugar with insulin or a sulfonylurea, and pancreatitis
- American Diabetes Association, alcohol and diabetes
- NIDDK, causes of pancreatitis
6 quick questions · about a minute · no email needed